Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nik Krajnc

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Biomolecules|September 28, 2021
Measuring Treatment Response in Progressive Multiple Sclerosis-Considerations for Adapting to an Era of Multiple Treatment OptionsNik Krajnc, Thomas Berger, Gabriel Bsteh
Frontiers in Neurology|September 13, 2021
Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic ReviewNik Krajnc, Gabriel Bsteh, Thomas Berger
Current Opinion in Neurology|April 8, 2026
Assessing treatment response in multiple sclerosisFabian Föttinger, Nik Krajnc, Gabriel Bsteh
Clinical Neurology and Neurosurgery|May 21, 2021
Pulmonary embolism in patients with multiple sclerosis treated with teriflunomide: A series of three casesNik Krajnc, Gregor Brecl Jakob, Sarah Gomezelj, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 5, 2022
Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk ManagementNik Krajnc, Gabriel Bsteh, Thomas Berger, et al.
Journal of Neurology|December 24, 2024
Antiplatelet therapy is not associated with increased risk of complications after lumbar punctureLaura Stichaller, Nik Krajnc, Fritz Leutmezer, et al.
Journal of Clinical Medicine|June 12, 2026
Reliability of Macular Ganglion Cell-Inner Plexiform Layer Thickness Measurements Across Scan Protocols in Spectral-Domain Optical Coherence TomographyNik Krajnc, Martin Bertich, Fabian Föttinger, et al.
Digital Health|July 18, 2022
Remote visits for people with multiple sclerosis during the COVID-19 pandemic in Austria: The TELE MS randomized controlled trialPatrick Altmann, Fritz Leutmezer, Markus Ponleitner, et al.
Frontiers in Neurology|March 24, 2022
Association of Cerebrospinal Fluid Parameters and Neurofilament Light Chain With Retinal Nerve Fiber Layer Thickness in Multiple SclerosisNik Krajnc, Patrick Altmann, Katharina Riedl, et al.
Multiple Sclerosis and Related Disorders|May 31, 2022
Has the pandemic changed treatment strategy in multiple sclerosis?Gabriel Bsteh, Katharina Riedl, Nik Krajnc, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Biomolecules|September 28, 2021
Measuring Treatment Response in Progressive Multiple Sclerosis-Considerations for Adapting to an Era of Multiple Treatment OptionsNik Krajnc, Thomas Berger, Gabriel Bsteh
Frontiers in Neurology|September 13, 2021
Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic ReviewNik Krajnc, Gabriel Bsteh, Thomas Berger
Current Opinion in Neurology|April 8, 2026
Assessing treatment response in multiple sclerosisFabian Föttinger, Nik Krajnc, Gabriel Bsteh
Clinical Neurology and Neurosurgery|May 21, 2021
Pulmonary embolism in patients with multiple sclerosis treated with teriflunomide: A series of three casesNik Krajnc, Gregor Brecl Jakob, Sarah Gomezelj, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 5, 2022
Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk ManagementNik Krajnc, Gabriel Bsteh, Thomas Berger, et al.
Journal of Neurology|December 24, 2024
Antiplatelet therapy is not associated with increased risk of complications after lumbar punctureLaura Stichaller, Nik Krajnc, Fritz Leutmezer, et al.
Journal of Clinical Medicine|June 12, 2026
Reliability of Macular Ganglion Cell-Inner Plexiform Layer Thickness Measurements Across Scan Protocols in Spectral-Domain Optical Coherence TomographyNik Krajnc, Martin Bertich, Fabian Föttinger, et al.
Digital Health|July 18, 2022
Remote visits for people with multiple sclerosis during the COVID-19 pandemic in Austria: The TELE MS randomized controlled trialPatrick Altmann, Fritz Leutmezer, Markus Ponleitner, et al.
Frontiers in Neurology|March 24, 2022
Association of Cerebrospinal Fluid Parameters and Neurofilament Light Chain With Retinal Nerve Fiber Layer Thickness in Multiple SclerosisNik Krajnc, Patrick Altmann, Katharina Riedl, et al.
Multiple Sclerosis and Related Disorders|May 31, 2022
Has the pandemic changed treatment strategy in multiple sclerosis?Gabriel Bsteh, Katharina Riedl, Nik Krajnc, et al.
Pageof 7